Records View

Comparison of the effectiveness between TENS(Transcutaneous electrical nerve stimulation), manual acupuncture, and electroacupuncture on patients with tinnitus : pilot study

Status Approved

  • First Submitted Date

    2016/09/06

  • Registered Date

    2016/10/21

  • Last Updated Date

    2016/10/12

CRIS Required

WHO ICTRP (International Clinical Trial Registry Platform) Required

  • 1. Background

    Background - CRIS Registration Number, Unique Protocol ID, Public/Brief Title, Scientific Title, Acronym, MFDS Regulated Study, IND/IDE Protocol, Registered at Other Registry, Name of Registry/Registration Number
    CRIS
    Registration Number
    KCT0002117
    Unique Protocol ID KOMCIRB-160321-HR-012
    Public/Brief Title Comparison of the effectiveness between TENS(Transcutaneous electrical nerve stimulation), manual acupuncture, and electroacupuncture on patients with tinnitus : pilot study
    Scientific Title Comparison of the effectiveness between TENS(Transcutaneous electrical nerve stimulation), manual acupuncture, and electroacupuncture on patients with tinnitus : pilot study
    Acronym
    MFDS Regulated Study No
    IND/IDE Protocol No
    Registered at Other Registry No
    Healthcare Benefit Approval Status
  • 2. Institutional Review Board / Ethics Committee

    Institutional Review Board Information
    Board Approval Status Submitted approval
    Board Approval Number KOMCIRB-160321-HR-012
    Approval Date 2016-05-13
    Institutional Review Board Name KYUNG HEE UNIVERSITY KOREAN MEDICINE HOSPITAL INSTITUTIONAL REVIEW BOARD
    Institutional Review Board Address
    Institutional Review Board Telephone
    Data Monitoring Committee No
  • 3. Contact Details

    Contact Details Information - Contact Person for Principal Investigator / Scientific Queries, Contact Person for Public Queries, Contact Person for Updating Information의 Name, Title, Email, Telephone, Cellular Phone, Affiliation, Address
    Contact Person for Principal Investigator / Scientific Queries
    Name HAE JUNG NAM
    Title Associate Professor
    Telephone +82-2-958-9244
    Affiliation Kyung Hee University
    Address 26, Kyungheedae-ro, Dongdaemun-gu, Seoul, Korea
    Contact Person for Public Queries
    Name YOUNG KYUN MOON
    Title Resident
    Telephone +82-2-958-9181
    Affiliation Kyung Hee University Oriental Medical Center
    Address 23, Kyungheedae-ro, Dongdaemun-gu, Seoul, Korea
    Contact Person for Updating Information
    Name YOUNG KYUN MOON
    Title Resident
    Telephone +82-2-958-9181
    Affiliation Kyung Hee University Oriental Medical Center
    Address 23, Kyungheedae-ro, Dongdaemun-gu, Seoul, Korea
  • 4. Status

    Status Information - Study Site, Overall Recruitment Status, Date of First Enrollment, Status of First Enrollment, Target Number of Participant, Primary Completion Date, Recruitment Status by Participating Study Site, Name of Study Site, Recruitment Status, Date of First Enrollment, Status of First Enrollemnt
    Study Site Single
    Overall Recruitment Status Recruiting
    Date of First Enrollment 2016-07-14 Actual
    Target Number of Participant 45
    Primary Completion Date 2017-06-30 , Anticipated
    Study Completion Date 2017-06-30 , Anticipated
    Recruitment Status by Participating Study Site 1
    Name of Study Kyung Hee University Oriental Medical Center
    Recruitment Status Recruiting
    Date of First Enrollment 2016-07-14 ,
  • 5. Source of Monetary / Material Support

    Source of Monetary / Material Support Information - Organization Name, Organization Type, Project ID
    1. Source of Monetary/Material Support
    Organization Name Kyung Hee University Oriental Medical Center
    Organization Type Medical Institute
    Project ID
  • 6. Sponsor Organization

    Sponsor Organization Information - Organization Name, Organization Type
    1. Sponsor Organization
    Organization Name Kyung Hee University Oriental Medical Center
    Organization Type Medical Institute
  • 7. Study Summary

    Study Summary Information
    Lay Summary
    1. Objective
    - The purpose of this study is to compare the effects of transcutaneous electric nerve stimulation (TENS), manual acupuncture (MA), and electroacupuncture (EA) on tinnitus.
    
    2. Background
    - Electrical stimulation treatments that have been utilized to treat tinnitus are TENS, TMS(transcranial magnetic stimulation), tDCS(transcranial direct current stimulation), subcutaneous occipital nerve stimulation, DBS(Deep Brain Stimulation), and EA.
    Non-invasive neuromodulations are TENS, TMS, tDCS, and so on. Due to the cost-effectiveness and safety of the treatment, TENS has been used for treating tinnitus since the 1970s. In studies that have utilized TENS in the treatment of tinnitus, electrode attachment sites were varied by temporomandibular joint (TMJ), pinna, tragus, and C2 dermatome (mastoid process). The response rate of patients treated with TENS varied greatly from 17.9% to 82% depending on the study. Among them, TENS on C2 dermatome is known to exhibit an inhibitory effect on tinnitus by increasing the effect of dorsal cochlear nucleus (DCN) in the central auditory nervous system.
     Acupuncture is a type of traditional Korean Medicne treatment that has been used since long ago for treating tinnitus. Although its mechanism is complex, it is believed that acupuncture improves certain kind of tinnitus by stimulating somatosensory system.
     EA is a treatment using acupuncture needles with electrical stimulation. For this reason, it is considered to have both characteristics of manual acupuncture and electrical stimulation therapy.
     Wang et al. reported a significant improvement of subjective tinnitus symptom in the EA group compared to the manual acupuncture group shortly after 6 weeks of treatment. However, the furthur study is necessay since the studies on the effects of EA for tinnitus are scarce.
     This study was designed to compare the effectiveness of TENS, EA, and acupuncture. The results of this study will help to determine the first line treatment of tinnitus.
    
    3. Clinical research plan
    - 45 patients who meet the inclusion criteria and none of exclusion criteria after screening are randomly assigned to TENS group, EA group, and MA group, respectively by 15. Afterwards, patients will be treated twice a week for five weeks. A follow-up will be conducted four weeks after the end of treatment.
    Subjective tinnitus loudness and annoyance perception wil be graded using VAS every visit.  THI, HRV(Heart Rate Variability), skin conductance and audiometric test will be performed at visit1, 5, 10, and follow-up session. 
     TENS treatment will be performed by using SSP (Silver Spike Point, low frequency electrotherapeutic device – Pointron 801). A pair of electrodes are attached to the sternomastoid and lower mastoid process (C2) on the affected side, and another pair of electrodes was placed to a trigger point of masseter muscle and temporomandibular joint in front of the ear. Afterwards, 30Hz electrical stimulation was applied for 20 minutes. 
     Patients who are assigned as manual acupuncture(MA) group and electroacupuncture(EA) group will receive acupuncture at 11 acupoints(TE21, SI19, GB2, TE22, ST7, TE17, GB20 of affected side, and GB20, TE05, KI3 of both sides) using sterilized disposable stainless needle of 0.25mm diameter and 40mm in length. Needling depth is approximately 5~10mm, it might depend on the differences of anatomical structure and individual characteristics of acupoints. Neddles will be retained for 20 minutes.
     EA group pateints will receive electrical stimulation at TE21, SI19 and TE17, GB20 of afftected side of tinnitus at mixed frequency 30/90Hz interval 3sec after the needles are inserted into acupoints.
     Both The stimulation intensity will be adjusted to relatively high but neither unpleasant nor painful level.
  • 8. Study Design

    Study Design Information - Study Type, Study Purpose, Phase, Intervention Model, Blinding/Masking, Blinded Subject, Allocation, Intervention Type, Intervention Description, Number of Arms, Arm Label, Target Number of Participant, Arm Type, Arm Description
    Study Type Interventional Study
    Study Purpose
    Treatment
    Phase Not applicable
    Intervention Model Parallel  
    Blinding/Masking Open
    Allocation RCT
    Intervention Type Medical Device  
    Intervention Description
     TENS treatment will be performed by using SSP (Silver Spike Point, low frequency electrotherapeutic device – Pointron 801). A pair of electrodes are attached to the sternomastoid and lower mastoid process (C2) on the affected side, and another pair of electrodes was placed to a trigger point of masseter muscle and temporomandibular joint in front of the ear. Afterwards, 30Hz electrical stimulation was applied for 20 minutes. The stimulation will be adjusted as relatively high intensity but neither unpleasant nor painful.
     Patients who are assigned as manual acupuncture(MA) group and electroacupuncture(EA) group will receive acupuncture at 11 acupoints(TE21, SI19, GB2, TE22, ST7, TE17, GB20 of affected side, and GB20, TE05, KI3 of both sides) using sterilized disposable stainless needle of 0.25mm diameter and 40mm in length. Needling depth will be approximately 5~10mm, depending on the differences of anatomical structure and individual characteristics of acupoints. It is advisable to retain the needles for 20 minutes.
     In the case of EA group, after the needles are inserted into acupoints metioned above, will receive electrical stimulation at TE21, SI19 and TE17, GB20 of afftected side of tinnitus at mixed frequency 30/90Hz interval 3sec. Stimulation intensity needs to be relatively high but neither unpleasant nor painful.
    
    Number of Arms 3
    Arm 1

    Arm Label

    TENS(Transcutaneous Electrical Nerve Stimulation) treatment group

    Target Number of Participant

    15

    Arm Type

    Experimental

    Arm Description

     TENS treatment will be performed by using SSP (Silver Spike Point, low frequency electrotherapeutic device – Pointron 801). A pair of electrodes are attached to the sternomastoid and lower mastoid process (C2) on the affected side, and another pair of electrodes was placed to a trigger point of masseter muscle and temporomandibular joint in front of the ear. Afterwards, 30Hz electrical stimulation was applied for 20 minutes. The stimulus intensity needed to be relatively high but neither unpleasant nor painful.
    
    Arm 2

    Arm Label

    Manual Acupuncture treatment group

    Target Number of Participant

    15

    Arm Type

    Active comparator

    Arm Description

     Patients who are assigned as manual acupuncture(MA) group and electroacupuncture(EA) group will receive acupuncture at 11 acupoints(TE21, SI19, GB2, TE22, ST7, TE17, GB20 of affected side, and GB20, TE05, KI3 of both sides) using sterilized disposable stainless needle of 0.25mm diameter and 40mm in length. Needling depth will be approximately 5~10mm, depending on the differences of anatomical structure and individual characteristics of acupoints. Acupuncture needles will be retained for 20 minutes.
    Arm 3

    Arm Label

    Electroacupuncture treatment group

    Target Number of Participant

    15

    Arm Type

    Active comparator

    Arm Description

    After the needles are inserted into acupoints metioned above, will receive electrical stimulation at TE21, SI19 and TE17, GB20 of afftected side of tinnitus at mixed frequency 30/90Hz interval 3sec. Stimulation intensity will be relatively high but neither unpleasant nor painful.
  • 9. Subject Eligibility

    Subject Eligibility Information
    Condition(s)/Problem(s) * (H60-H95)Diseases of the ear and mastoid process 
       (H93.1)Tinnitus 
    Rare Disease No
    Inclusion Criteria

    Gender

    Both

    Age

    20Year~75Year

    Description

    1. Men and women aged 20 to 75
    2. Patients with persistent tinnitus for 6 months or more
    3. Patients who have agreed not to receive any type of medical treatment from another hospital to treat tinnitus
    4.  Patients who voluntarily choose to participate in the study  
    Exclusion Criteria
    1. Patients who have undergone tinnitus treatment such as acupuncture and TENS within three months
    2. Patients who have medicines and surgical procedures due to cardiac disorder, or patients with pacemaker implants 
    3. Patients with disease—meniere’s disease, tympanitis, and otosclerosis—that certainly can cause tinnitus
    4. Patients who have metal allergies and needle phobia
    5. Patients who take psychoactive drugs to treat tinnitus symptoms
    6. Patients who gave birth within six months, or patients who are currently pregnant or breastfeeding   
    7. Patients who are unable to perform evaluation test and complete the questionnaire 
    8. Patients who are considered unsuitable for the study based on the opinion of the investigators
    Healthy Volunteers
  • 10. Outcome Measure(s)

    Outcome Measure(s) Information - Type of Primary Outcome, Primary Outcome, Outcome, Timepoint, Secondary Outcome, Outcome, Timepoint
    Type of Primary Outcome Efficacy
    Primary Outcome(s) 1
    Outcome
    respond rate of Tinnitus Handicap Inventory(THI) - evaluated as a responder if THI score improved more than 10 points
    Timepoint
    Baseline, visit 5, end of treatments(visit 10), follow-up visit(visit11, 4 weeks after the end of treatment sessions)
    Secondary Outcome(s) 1
    Outcome
    THI score
    Timepoint
    Baseline, visit 5, end of treatments(visit 10), follow-up visit(visit11, 4 weeks after the end of treatment sessions)
    Secondary Outcome(s) 2
    Outcome
    VAS(loudness, annoyance)
    Timepoint
    VAS : every visit (before and after the treatment in the treatment visits)
    Secondary Outcome(s) 3
    Outcome
    Pure tone audiometry(PTA)
    Timepoint
    Baseline, visit 5, end of treatments(visit 10), follow-up visit(visit11, 4 weeks after the end of treatment sessions)
    Secondary Outcome(s) 4
    Outcome
    Speech Discrimination(SD)
    Timepoint
    Baseline, visit 5, end of treatments(visit 10), follow-up visit(visit11, 4 weeks after the end of treatment sessions)
    Secondary Outcome(s) 5
    Outcome
    skin conductance
    Timepoint
    Baseline, visit 5, end of treatments(visit 10)
    Secondary Outcome(s) 6
    Outcome
    Heart Rate Variability(HRV)
    Timepoint
    Baseline, visit 5, end of treatments(visit 10)
  • 11. Study Results and Publication

    Study Results and Publication Information - Result Registered, Final Enrollment Number, Number of Publication, Publications, Results Upload, Date of Posting Results, Protocol URL or File Upload, Brief Summary
    Result Registered
  • 12. Sharing of Study Data(Deidentified Individual-Patient Data, IPD)

    Sharing of Study Data Information - Sharing Statement, Time of Sharing, Way of Sharing
    Sharing Statement Not provided at time of Registration
화면 최상단으로 이동

TOP

BOTTOM

화면 최하단으로 이동